Conversely, FBXO6 overexpression led to a marked decrease in RNASET2 protein expression in a dose-dependent manner, clearly suggesting that FBXO6 is involved in the degradation of RNASET2 protein in both ovarian cancer cell models. This evidence concerns the gene FBXO6 and ovarian cancer.